AAAAAA

   
Results: 1-8 |
Results: 8
A randomized, controlled trial of remacemide for motor fluctuations in Parkinson's disease
Authors: Shoulson, I Penney, J McDermott, M Kieburtz, K Schwid, SR Kayson, E Chase, T Fahn, S Greenamyre, JT Lang, A Siderowf, A Pearson, N Harrison, M Rost-Ruffner, E Colcher, A Lloyd, M Matthews, M Pahwa, R McGuire, D Lew, MF Schuman, S Marek, K Broshjeit, S Factor, S Brown, D Feigin, A Mazurkiewicz, J Ford, B Jennings, D Dillon, S Comella, C Blasucci, L Janko, K Shulman, L Wiener, W Bateman-Rodriguez, D Carrion, A Suchowersky, O Lafontaine, AL Pantella, C Siemers, E Belden, J Davies, R Lannon, M Grimes, D Gray, P Martin, W Kennedy, L Adler, C Newman, S Hammerstad, J Stone, C Lewitt, P Bardram, K Mistura, K Miyasaki, J Johnston, L Cha, JHJ Tennis, M Panisset, M Hall, J Tetrud, J Friedlander, J Hauser, R Gauger, L Rodnitzky, R Deleo, A Dobson, J Seeberger, L Dingmann, C Tarsy, D Ryan, P Elmer, L Ruzicka, D Stacy, M Brewer, M Locke, B Baker, D Casaceli, C Day, D Florack, M Hodgeman, K Laroia, N Nobel, R Orme, C Rexo, L Rothenburgh, K Sulimowicz, K Watts, A Wratni, E Tariot, P Cox, C Leventhal, C Alderfer, V Craun, AM Frey, J McCree, L McDermott, J Cooper, J Holdich, T Read, B
Citation: I. Shoulson et al., A randomized, controlled trial of remacemide for motor fluctuations in Parkinson's disease, NEUROLOGY, 56(4), 2001, pp. 455-462
The cost of delaying treatment in multiple sclerosis - What is lost is notregained
Authors: Schwid, SR Bever, CT
Citation: Sr. Schwid et Ct. Bever, The cost of delaying treatment in multiple sclerosis - What is lost is notregained, NEUROLOGY, 56(12), 2001, pp. 1620-1620
Are quantitative functional measures more sensitive to worsening MS than traditional measures?
Authors: Schwid, SR Goodman, AD Apatoff, BR Coyle, PK Jacobs, LD Krupp, LB Miller, AE Wende, KE Brownscheidle, CM
Citation: Sr. Schwid et al., Are quantitative functional measures more sensitive to worsening MS than traditional measures?, NEUROLOGY, 55(12), 2000, pp. 1901-1903
Lessons from linomide - A failed trial, but not a failure
Authors: Schwid, SR Trotter, JL
Citation: Sr. Schwid et Jl. Trotter, Lessons from linomide - A failed trial, but not a failure, NEUROLOGY, 54(9), 2000, pp. 1716-1717
The impact of remacemide hydrochloride on levodopa concentrations in Parkinson's disease
Authors: Schwid, SR Kieburtz, K Nutt, J McDermott, M Kayson, E Chase, T Fahn, S Greenamyre, T Lang, A Penney, J Shoulson, I
Citation: Sr. Schwid et al., The impact of remacemide hydrochloride on levodopa concentrations in Parkinson's disease, CLIN NEUROP, 22(4), 1999, pp. 220-225
Therapy of relapsing multiple sclerosis. Treatment approaches for nonresponders
Authors: Cohen, JA Carter, JL Kinkel, RP Schwid, SR
Citation: Ja. Cohen et al., Therapy of relapsing multiple sclerosis. Treatment approaches for nonresponders, J NEUROIMM, 98(1), 1999, pp. 29-36
Quantitative assessment of motor fatigue and strength in MS
Authors: Schwid, SR Thornton, CA Pandya, S Manzur, KL Sanjak, M Petrie, MD McDermott, MP Goodman, AD
Citation: Sr. Schwid et al., Quantitative assessment of motor fatigue and strength in MS, NEUROLOGY, 53(4), 1999, pp. 743-750
Targeting immunotherapy in multiple sclerosis - A near hit and a clear miss
Authors: Schwid, SR Noseworthy, JH
Citation: Sr. Schwid et Jh. Noseworthy, Targeting immunotherapy in multiple sclerosis - A near hit and a clear miss, NEUROLOGY, 53(3), 1999, pp. 444-445
Risultati: 1-8 |